Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-22

FDA Approved: ESZOPICLONE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Eszopiclone from Teva Pharmaceuticals USA, Inc., related to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eszopiclone (eszopiclone)

Snippet

SUPPL AP for ESZOPICLONE (ESZOPICLONE)